Myotonic dystrophy quantification muscle weakness myotonia effect amitriptyline exercise purpose study degree muscle weakness myotonia patients myotonic dystrophy MD effects four- six-month therapeutic trial amitriptyline Patients weights years initial improvement muscle strength plateau others study Muscle weakness five-second maximum voluntary contraction MVC newtons kg body weight patients healthy subjects Knee extensor elbow flexor first dorsal interosseous FDI muscles Myotonia relaxation times RTs end five-second MVC FDI time MVC results mean muscle strength muscles patients healthy subjects means patients vs healthy subjects patients therapeutic trial amitriptyline Therapeutic effects muscle strength percent change evoked muscle action potential MAP FDI muscle ten-second MVC change excitability Mean muscle strength FDI 